Tanabe AAI LLC, a joint venture between Tanabe Seiyaku Co Ltd and aaiPharma Inc, is developing TA-2711E, an enema formulation of Tanabe's mucosal protectant ecabet, for the potential treatment of ulcerative colitis. By July 2004, phase III trials for ulcerative colitis had been initiated in Japan and phase II studies were ongoing in Europe and the US; this remained the case in May 2006.

Monteleone, G., Caprioli, F. (2007). Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 8(5), 423-428.

Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis

MONTELEONE, GIOVANNI;
2007-01-01

Abstract

Tanabe AAI LLC, a joint venture between Tanabe Seiyaku Co Ltd and aaiPharma Inc, is developing TA-2711E, an enema formulation of Tanabe's mucosal protectant ecabet, for the potential treatment of ulcerative colitis. By July 2004, phase III trials for ulcerative colitis had been initiated in Japan and phase II studies were ongoing in Europe and the US; this remained the case in May 2006.
2007
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/12 - GASTROENTEROLOGIA
English
12 sulfodehydroabietic acid; corticosteroid; immunosuppressive agent; mesalazine; panitumumab; prednisolone; salazosulfapyridine; steroid; clinical trial; constipation; defecation habit; diarrhea; drug withdrawal; Europe; human; Japan; nausea; nonhuman; review; side effect; ulcerative colitis; United States; Administration, Rectal; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Colitis, Ulcerative; Diterpenes, Abietane; Enema; Humans; Treatment Outcome
Monteleone, G., Caprioli, F. (2007). Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis. CURRENT OPINION IN INVESTIGATIONAL DRUGS, 8(5), 423-428.
Monteleone, G; Caprioli, F
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/43068
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact